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The effect of a glucocortrcoid on protein synthesis in human polymorphonuclear leucocytes (PMNLs) was 
investigated by two-dimensional gel electrophoresis. In the peripheral biood PMNLs of healthy laboratory 
personnel. the rate of incorporation of L-[35S]methionine into a least rune poIypeptides was consistently m- 
fluenced by dexamethasone in a dose-dependent manner, being increased in the case of seven polypeptides 
and decreased in the remamder. 
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1. INTRODUCTION 
Ghrcocorticoids exert an anti-in~ammatory ef- 
fect, both clinically in humans and also in a variety 
of animal models of inflammation such as the 
carrageenin-induced pouch in rats [l]. One of the 
cell types involved in acute inflammation is the 
phagocytic PMNL which migrates from the cir- 
culation to the site of inflammation. Chemotactic 
activity for PMNLs increases at this site and is at- 
tributable in the early stages of inflammation to 
leukotriene B4 [2], a lipoxygenase metabolite of 
arachidonic acid. 
PMNLs possess receptors for glucocorticoids (31 
and gene transcriptjon is presumed to be affected 
in them in a manner similar to that in the classic 
glucocorticoid target cells such as the hepatocytes 
and thymocytes. Amongst the biological effects of 
glucocorticoids upon PMNLs are a receptor- 
mediated suppression of phosphoIipase Az-depen- 
dent release of arachidonic acid 141, a reduction in 
Abbreviations: PMNLs, polymorphonuclear Ieucocytes; 
PAGE, polyacrylamide-gel lectrophoresis; IEF, isoelec- 
tric focusing; NEPHGE, non-equilibrium pH gradient 
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chemotactic activity released into the medium [5], 
and an inhibition of plasminogen activator pro- 
duction [6]. Induction of synthesis of a protein in- 
hibitor of phospho~ipase AZ, termed macrocortin 
or lipomoduhn [7], has been identified in several 
cell types, including rabbit PMNLs, in response to 
incubation with glucocorticoids. However, it is not 
yet established whether this accounts fully for all 
the effects of glucocorticoid seen in PMNLs in 
vivo and in vitro, nor whether g~ucocorticoids in- 
fluence the synthesis of other proteins by PMNLs. 
As a first step towards resolving these questions, 
we have pulse-labelled human peripheral blood 
PMNLs with L-[35S]methionine in the presence 
and absence of dexamethasone, a synthetic gluco- 
corticoid, and subjected the cell homogenates, 
prepared in the presence of a protease inhibitor, to 
two-dimensional gel electrophoresis. The synthesis 
of a number of polypeptides was found to be in- 
duced or repressed ose-dependently in response to 
dexamethasone. 
2. MATERIALS AND METHODS 
2.1. Materials 
Dextran T500 and Percoll were obtained from 
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Pharmacia, Dulbecco’s Ca and Mg free phos- 
phate-buffered saline (PBS) and RPM1 1640 
medium from Gibco, L-[“Slmethionine (high 
specific activity) from Amersham, and Protosol 
from New England Nuclear. 
2.2. Preparation of PMNLs 
Venous blood from healthy volunteers was 
treated with EDTA and diluted with 0.5 vol PBS 
and the red cells allowed to sediment in the 
presence of 1.5% dextran at 37°C. In all further 
procedures, the cells were kept cold. The cells in 
the supernatant were separated on a 55%/67.8% 
Percoll in PBS step gradient and PMNLs were col- 
lected from the concentration boundary. PMNLs 
were washed twice in PBS, residual red cells being 
lysed by a 30 s hypotonic (0.2Yo PBS) incubation 
on ice, washed twice more in PBS and once briefly 
in RPM1 1640. All solutions were sterile prior to 
use. 
2.3. Incubation of PA4NLs and preparation of 
material for PAGE 
Aliquots of 2 x lo6 cells were incubated for 4.5 
h in 200~1 RPM1 1640 medium lacking methionine 
but supplemented with 0.1% (w/v) bovine serum 
albumin and 64 units of gentamycin sulphate in an 
atmosphere of 5% CO2/95% air at 37°C either in 
the presence of vehicle (0.005% (v/v) ethanol) or 
in dexamethasone, concentration as indicated in 
figure legends. L-[35S]Methionine, 62.5 ,&i, was 
included during the final hour. Cells were then col- 
lected and washed twice in cold PBS containing 5 
mM unlabelled methionine, and solubilised in 80~1 
lysis buffer [8] containing 1 mM phenylmethyl- 
sulphonyl fluoride and 2% ampholines (1.6% pH 
5-8, 0.4% pH 3.5-10; LKB). The samples were 
freeze-thawed 5 times prior to loading onto the 
gels, to shear DNA. 
2.4. Electrophoresis and fluorography 
Either IEF for 16.5 h at 400 V followed by 1 h 
at 800 V, or NEPHGE for 4.5 h at 400 V was used 
as the first dimension of two-dimensional gel elec- 
trophoresis as in [8,9]. Tube gels (12.5 cm x 2 mm 
diam.) were then equilibrated with SDS-containing 
sample buffer for 2x20 min prior to applying to 
15% (w/v) polyacrylamide slab gels. Electro- 
phoresis in the second dimension was for 17 h at 55 
V, and matched pairs of dexamethasone or vehicle 
treated samples were run concurrently in the same 
tank. Gels were prepared for fluorography as in 
[lo] and exposed to Fuji RX medical X-ray film at 
-70” for 7-14 days. 
2.5. Gel solubilisation and assay for radioactivity 
Labelled polypeptide spots of interest were ex- 
cised from the dried gel by aligning with the X-ray 
film. They were rehydrated, incubated with 0.2 ml 
Protosol overnight at 37°C and assayed for radio- 
activity with non-aqueous scintillant. 
3. RESULTS 
Circulating PMNLs have a low protein synthetic 
activity and are not thought to require protein syn- 
thesis for two of their major activities, viz, chemo- 
taxis and phagocytosis. Furthermore, the cells have 
a short half-life in vivo and in vitro. PMNLs from 
5 healthy volunteers were incubated for 4.5 h over 
which time their viability remained higher than 
92% as shown by the nigrosine exclusion test. 
Pulse-labelling with L-[35S]methionine was be- 
tween 3.5 and 4.5 h. Cells incubated in vehicle in- 
corporated l-2.5 x lo6 cpm per 10’ cells per h in 
these conditions and cells incubated with 1 PM dex- 
amethasone incorporated methionine at 70-90% 
of this rate. The fluorograms of two-dimensional 
polyacrylamide-gels using IEF in the first dimen- 
sion show polypeptides of isoelectric point between 
5.0 and 7.5 into which labelled methionine has 
been incorporated in a l-h pulse. The two-dimen- 
sional (IEF) PAGE pattern of polypeptides from 
cells of one of 5 healthy volunteers is shown in 
fig. 1, incubated with vehicle (A) or dexamethasone 
(B). Although the overall profiles from the 5 
volunteers possess dissimilarities, the rate of 
methionine incorporation into the polypeptides 
marked 1-6 in fig. 1B is increased in all 5 in- 
dividuals, and into polypeptides Rl, R2 (fig. 1A) is 
decreased in each case. No other changes due to 
dexamethasone have been observed in any of the 
volunteers. An increase in rate of methionine in- 
corporation with dexamethasone incubation into 
one other more basic polypeptide was detected us- 
ing NEPHGE in the first dimension (polypeptide 
7, fig.lC,D). Also marked in fig.lD are the posi- 
tions of polypeptides induced by dexamethasone 
which correspond to polypeptides 4 and 6 on 
fig.lB. The M, values of polypeptides l-7 were as 
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Fig: 1. Fluorograms of two-dimensional polyacrylamide-gels of pulse-labelled PMNL proteins from cells incubated in 
the presence of vehicle (A,C) or 1 hM dexamethasone (B,D). Approximately equal amounts of label from vehicle-treated 
and dexamethasone-treated samples were applied to matched pairs of gels. (A,B): IEF in the first dimension; (C,D): 
NEPHGE in the first dimension. Also shown are the positions of M, marker proteins run in the second dimension 
alongside first dimension gels. Dexamethasone-affected polypeptides are indicated by numbered arrows and the position 
of actin (a) is shown, identified by 2-dimensional electrophoresis of muscle actin and M, marker proteins run concur- 
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follows: 1,2=55000; 3=29000; 4=27000; 5 = 
22000; 6=16000; 7=49000. The M, values of Rl 
and R2 were 55 000 and 28 000, respectively. 
The effect of dexamethasone concentration on 
the induction of these changes in polypeptide syn- 
thesis was investigated by incubating cells from 
one volunteer in either vehicle or 1 nM, 10 nM, 100 
nM, 1 PM or 10 PM dexamethasone. Pulse la- 
belling was as before and each sample was sub- 
jected to two-dimensional PAGE with IEF or 
NEPHGE in the first dimension. The degree of ef- 
fect due to dexamethasone was observed to in- 
crease with dexamethasone dose over the range O-l 
PM at 3.5-4.5 h. The two most highly labelled 
spots induced by dexamethasone (polypeptide 4 in 
fig. lD, polypeptide 6 in fig. 1B) are shown in 
fig.2A. They were excised from each gel and 
assayed for radioactivity along with 5 unaffected 
polypeptides, which acted as reference points bet- 
ween gels. Small variations in sample loading, loss 
in equilibration and second dimension gel penetra- 
tion were accounted for by comparing radioactivi- 
ty in the 5 unaffected polypeptides in each gel with 
reference to unaffected polypeptides in vehicle- 
treated samples, and correcting the radioactivity in 
induced polypeptides accordingly. 
The dose-effect curve for the 16-kDa polypep- 
tide (fig.2B) shows a 4.7-fold stimulation in the 
rate of synthesis of the polypeptide with 1 PM dex- 
amethasone over the rate in hormone-free cells. 
Half-maximal response occurs around 10 nM dex- 
amethasone, a concentration sufficient to saturate 
half the number of putative dexamethasone r cep- 
tors in human PMNLs [3]. Incorporation of 
methionine into the 27-kDa polypeptide also in- 
creases with dexamethasone at the time point 
studied, with a maximum 3-fold stimulation in 
synthesis at 1 PM, but it is less affected by lower 
dexamethasone concentrations (10 nM and less). 
This may be because induction of this polypeptide 
does not commence until the second or third hour 
of incubation even using receptor-saturating levels 
of dexamethasone (results to be presented else- 
where). The full effect of dexamethasone on the 
27-kDa polypeptide at lower concentrations may 
therefore not be seen until after 4.5 h. By contrast, 
an increased rate of methionine incorporation into 
the 16-kDa polypeptide is seen as an early event in 
response to dexamethasone, it being 70% maximal 
within the first hour. 
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Fig.2. Effect of dexamethasone concentration on the in- 
corporation of L-[35S]methionine by PMNLs into two 
polypeptides. (A) Sections of fluorograms howing (i) 
16-kDa polypeptide from IEFR-dimensional PAGE and 
(ii) 27-kDa polypeptide from NEPHGE/2-dimensional 
PAGE, pulse-labelled in cells treated with 0,l nM, 10 
nM, or 100 nM dexamethasone. (B) The polypeptides 
were excised from the gels shown in (A), solubilised and 
assayed for radioactivity. Dexamethasone concentra- 
tion-dependent incorporation of L-[35S]methionine into 
1dkDa polypeptide (H) and 27-kDa polypeptide 
(O--O) is shown after correction for small variations in 
overall amount of label between gels as assessed in S 
dexamethasone-unaffected polypeptides. 
4. DISCUSSION 
Dexamethasone consistently induced an in- 
creased rate of L-[35S]methionine incorporation in- 
to at least 7 polypeptides and decreased the rate in- 
to at least two polypeptides in the PMNLs of all 5 
healthy laboratory personnel investigated. Syn- 
thesis of polypeptides with A4, 16000 and 27 000 
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was quantifiable and was found to be dexametha- 
sone concentration-dependent over the range O-l 
PM. Such dependence was most pronounced be- 
tween 0 and 100 nM dexamethasone, the concen- 
tration range over which the PMNL glucocorticoid 
receptors become saturated [3]. These results do 
not preclude the possibility of there being other 
dexamethasone-inducible polypeptides which, for 
instance, do not contain methionine, or are 
masked by adjacent, more prominently labelled 
polypeptides. 
This study is based on methods used previously 
to detect glucocorticoid-induced proteins in other 
cell types such as hepatoma tissue-culture cells [ 1 l] 
and thymus cells [12]. In hepatoma cells, none of 
the class I induced polypeptides appear to corres- 
pond to any of the induced polypeptides shown 
here, whilst from thymus cells, only one induced 
polypeptide, that of M, 22000, appears to occupy 
a similar electrophoretic position to the polypep- 
tide of corresponding molecular mass induced in 
PMNLs. 
It is not yet known what roles these glucocorti- 
coid-inducible polypeptides of PMNLs have, or 
even if all the polypeptides represent functionally 
separate activities, since some could prove to be 
sub-units of larger proteins. However, the induc- 
tion of protein inhibitors of phospholipase AZ by 
glucocorticoids has been observed in a number of 
cell types, including rabbit PMNLs [4] and rat 
peritoneal macrophages [13]. Inhibition of phos- 
pholipase AZ leads to a reduction in arachidonic 
acid production and its pro-inflammatory meta- 
bolites, leukotrienes and prostaglandins [4]. Most 
of the anti-phospholipase activity has been found 
in 39-44 kDa fractions with some in a 16-kDa 
fraction [ 141. It remains to be seen whether any of 
the polypeptides identified in the present study as 
dexamethasone-inducible are phospholipase in- 
hibitory or what other roles they might have. We 
believe that further study of the effect of dexa- 
methasone upon these polypeptides will shed light 
on the anti-inflammatory activity of gluco- 
corticoids as seen in PMNLs. Furthermore, study 
of the induction of these polypeptides by dexame- 
thasone in PMNLs of patients with rheumatoid ar- 
thritis will determine more precisely the mode of 
therapeutic action of glucocorticoids in chronic 
autoimmune inflammatory and allergic disorders. 
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